Search
for
Sort by
Research 721–750 of 1000+
- Molecular basis of androgenetic alopecia: From androgen to paracrine mediators through dermal papilla
- Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
- Male-pattern baldness susceptibility locus at 20p11
- Androgenetic alopecia and cardiovascular risk factors in men and women: A comparative study
- Androgenetic Alopecia
- The unit area trichogram in the assessment of androgen-dependent alopecia
- Medical and Environmental Risk Factors for the Development of Central Centrifugal Cicatricial Alopecia
- Six Novel Susceptibility Loci for Early-Onset Androgenetic Alopecia and Their Unexpected Association with Common Diseases
- Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?
- Investigative guidelines for alopecia areata
- Finasteride in the treatment of alopecia
- Baldness and the androgen receptor: the AR polyglycine repeat polymorphism does not confer susceptibility to androgenetic alopecia
- Male pattern hair loss: current understanding
- The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.
- Topical minoxidil in male pattern baldness: Effects of discontinuation of treatment
- Early Onset of Androgenetic Alopecia Associated With Early Severe Coronary Heart Disease: A Population-Based, Case-Control Study
- Topical minoxidil therapy in hereditary androgenetic alopecia
- Male androgenetic alopecia
- Association of Benign Prostatic Hyperplasia with Male Pattern Baldness
- Lokaltherapie der Alopecia androgenetica mit 17α-Östradiol
- Susceptibility variants on chromosome 7p21.1 suggest HDAC9 as a new candidate gene for male-pattern baldness
- Increased Androgen Binding Capacity in Sebaceous Glands in Scalp of Male-pattern Baldness
- A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers
- Treatment of Male Pattern Baldness with Botulinum Toxin: A Pilot Study
- Association of Androgenetic Alopecia With Mortality From Diabetes Mellitus and Heart Disease
- What does androgenetic alopecia have to do with COVID‐19? An insight into a potential new therapy
- Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss
- The Histopathology of Noncicatricial Alopecia
- Testosterone metabolism in the skin. A review of its function in androgenetic alopecia, acne vulgaris, and idiopathic hirsutism including recent studies with antiandrogens
- Androgen receptor gene polymorphisms and risk for androgenetic alopecia: a meta-analysis